What makes DtC so attractive in medtech?
So why should you consider DtC as part of your strategy? Well, there are several reasons, the most obvious one being that you must do it to avoid being left behind and end up as purely a manufacturer. The other more detailed reasons (also highlighted in fig. 1) are:
Consumption: Most healthcare consumers need to use their product more than once a day. This means that consumption is relatively higher than the average fast-moving consumer goods or business-to-business product – something that increases value per consumer significantly.
Buyer involvement: The level of involvement is naturally high due to the consumer’s chronic condition. This means that healthcare companies do not need to create consumer involvement to the same extent as other business-to-consumer (BtC) and BtB markets. It is there from the get-go.
Price sensitivity: Most medical device products are either fully reimbursed or co-funded through insurance (depending on country). This means that price elasticity is naturally lower than other traditional consumer products. Also, the fact that a new medical device product can significantly improve the quality of life for a patient plays a vital role in this context.